Immunization stress-related response - Redefining immunization anxiety-related reaction as an adverse event following immunization.

AEFI Anxiety Clusters Immunization Immunization anxiety responses Immunization stress-related responses Stress

Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
23 03 2020
Historique:
received: 25 10 2019
revised: 11 02 2020
accepted: 16 02 2020
pubmed: 7 3 2020
medline: 10 4 2021
entrez: 6 3 2020
Statut: ppublish

Résumé

The Council for the International Organizations of Medical Sciences (CIOMS) and WHO working group on pharmacovigilance defines five cause specific AEFI which includes an immunization anxiety-related reaction. Historically this term has been used to describe a range of symptoms and signs that may arise after immunization that are related to "anxiety" about the immunization. However, the term "anxiety" does not adequately capture all the elements of this cause specific AEFI. In 2015, the Global Advisory Committee for Vaccine Safety convened an expert working group with the purpose of redefining, preventing and managing this particular AEFI. The term "Immunization Stress-Related Response" is proposed to replace the former terminology. We present a manual that redefines this AEFI and present a framework for prevention, diagnosis and management in both an individual and also when such events occur as clusters and affect multiple individuals. Since such mass events can result in cessation of immunization programmes and/or a loss of public confidence, a communication response is essential.

Identifiants

pubmed: 32131975
pii: S0264-410X(20)30258-9
doi: 10.1016/j.vaccine.2020.02.046
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3015-3020

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michael S Gold (MS)

Discipline of Paediatrics, School of Medicine, University of Adelaide, Australia. Electronic address: michael.gold@adelaide.edu.au.

Noni E MacDonald (NE)

Department of Paediatrics, Dalhousie University, IWK Health Centre, Halifax, Canada.

C Meghan McMurtry (CM)

Department of Psychology, University of Guelph, Guelph and Pediatric Chronic Pain Program, McMaster Children's Hospital, Hamilton, Ontario, Canada.

Madhava Ram Balakrishnan (MR)

Department of Essential Medicines and Health Products (EMP), World Health Organization, Genève, Switzerland.

Ulrich Heininger (U)

Division of Pediatric Infectious Diseases and Vaccinology, University of Basel Children's Hospital, Basel, Switzerland.

Lisa Menning (L)

Expanded Programme on Immunization, World Health Organisation, Geneva, Switzerland.

Oleg Benes (O)

Regional Office Europe, World Health Organisation, Denmark.

Robert Pless (R)

Clinical Evaluation Division, Vaccines/Blood Biologics and Genetic Therapies Directorate, Health Canada, Canada.

Patrick L F Zuber (PLF)

Department of Essential Medicines and Health Products (EMP), World Health Organization, Genève, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH